| About this Abstract |
| Meeting |
2023 TMS Annual Meeting & Exhibition
|
| Symposium
|
Biological Materials Science
|
| Presentation Title |
A Review of Nanovanadium Compounds for Cancer Cell Therapy |
| Author(s) |
Ikhazuagbe Hilary Ifijen, Nyaknno U. Udokpoh, Muniratu Maliki, Esther U. Ikhuoria, Efosa O. Obazee |
| On-Site Speaker (Planned) |
Muniratu Maliki |
| Abstract Scope |
Several vanadium compounds have shown promise as chemotherapeutics during the last few years. Vanadium compounds' rapid elimination from the body and potential toxicity have, nevertheless, impeded their ongoing expansion. In addition to circumventing these constraints, vanadium-based nanomaterials benefit from the intrinsic photics and magnetic properties of vanadium, which make them a multimodal platform for the detection and treatment of cancer. This review outlined the numerous studies that looked into the prospect of treating cancer cells with nanovanadium compounds over the years. The essential biological and pharmacological activities of vanadium-nanobased materials in cancer treatment are also highlighted. The numerous studies that looked into the prospect of treating cancer cells with nanovanadium compounds found a novel alternative channel for cancer-fighting medicinal techniques. |
| Proceedings Inclusion? |
Planned: |
| Keywords |
Biomaterials, Nanotechnology, Characterization |